Immune Checkpoint Inhibitor Efficacy Varies by Sex

THURSDAY, May 17, 2018 -- For patients with advanced cancers, treatment with immune checkpoint inhibitors is associated with improved overall survival, with the magnitude of the benefit sex-dependent, according to research published online May 16 in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news